Fenofibrate capsules are indicated as adjunctive therapy to diet for the reduction of LDL-C. Total-C. Triglycerides and apo B in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Lipid-altering…
Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated LDL-C. Total-C. Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and…
Treatment of Hypercholesterolemia. Fenofibrate tablets USP are indicated as adjunctive therapy to diet to reduce elevated LDL-C. Total-C. Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed…
1.1 Primary Hypercholesterolemia or Mixed Dyslipidemia Fenofibrate tablets for oral use are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C). Triglycerides and…
Treatment of Hypercholesterolemia. Fenofibrate tablets USP are indicated as adjunctive therapy to diet to reduce elevated LDL-C. Total-C. Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2022. All Rights Reserved.